|IJCEP Copyright © 2007-All rights reserved.
Int J Clin Exp Pathol 2013;6(7):1317-1326
Evolution in the diagnosis and treatment of autoimmune pancreatitis: experience from a
single tertiary care center
Alper Yurci, Tyler Stevens, Shetal N Shah, Ryan E Law, Matthew R Walsh, Lisa Yerian, Xiuli Liu
Digestive Disease Institute, Cleveland Clinic, Cleveland, Ohio, USA; Imaging Institute, Cleveland Clinic, Cleveland, Ohio, USA; Department of
Anatomic Pathology, Cleveland Clinic, Cleveland, Ohio, USA
Received May 17, 2013; Accepted June 1, 2013; Epub June 15, 2013; Published July 1, 2013
Abstract: Background: Autoimmune pancreatitis (AIP) is a recently characterized disease with specific clinical, radiographic, and histological
features. These diagnostic features have been codified in the recently revised HISORt criteria. The aim of this study was to determine how the
recognition and management of AIP has evolved at our center since the publication of the HISORt criteria in 2006. Methods: We conducted a
historical cohort study consisting of patients with AIP based on the revised HISORt criteria seen at our tertiary care center since 1990. Cases
were identified from pathology, laboratory, and pancreas clinic databases. The medical records were reviewed to ascertain demographic and
clinical characteristics, radiologic and laboratory results, and patient outcomes. When available, prior images and pathology slides were
retrospectively reviewed. The clinical outcomes of the patients were assessed following surgical or medical treatment, and compared based
on the calendar year of presentation (before or after 2006). Results: Forty-seven cases were identified based on the revised HISORt criteria. Of
these, 22 were evaluated before and 25 after January 1, 2006. In the early cohort, the diagnosis was frequently missed, including 15 patients
that underwent surgical resections. None from the early cohort had a serum IgG4 drawn or mention of possible AIP in the imaging reports.
When histology was obtained, the surgical pathologist did not perform IgG4 or Movat stain to allow a histological diagnosis of AIP. Several
patients developed diabetes (n=3), calcific pancreatitis with exocrine insufficiency (n=3), proximal biliary strictures (n=7), and pancreatic cancer
(n=1) during follow-up. In contrast, patients in the late cohort were less likely to undergo a surgical resection that the early cohort (36% vs. 68%,
p=0.042). They were more likely to have a serum IgG4 drawn (80% vs. 0%) and to undergo a corticosteroid trial (44% vs. 0%, p=0.0003). 10/11
patients (92%) who underwent corticosteroid trials had resolution of their symptoms and improvement in structural abnormalities on imaging.
Conclusion: A growing multidisciplinary awareness of AIP has led to improved diagnostic evaluation, prompter diagnosis, fewer surgical
resections, and more frequent corticosteroid trials. (IJCEP1305024).
Keywords: Autoimmune pancreatitis, IgG4, resection, corticosteroid
Address correspondence to: Dr. Xiuli Liu, Department of Anatomic Pathology, 9500 Euclid Avenue/L25, Cleveland Clinic, Cleveland, Ohio
44195, USA. Phone: 216-445-8745; Fax: 216-445-6967; E-mail: email@example.com